Clinical Trial Update: Longitudinal Endpoint Assessment of Disease Burden in HD

View source ↗

Summary

A Huntington disease clinical trial is currently recruiting to longitudinally assess disease burden endpoints.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Snippet

Sponsor: Huntington Study Group | Conditions: Huntington Disease | Status: RECRUITING